Live Breaking News & Updates on Nd Eq Us29446k1060

Stay updated with breaking news from Nd eq us29446k1060. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates

$71.0 million cash balance at the end of 2022 expected to provide cash runway into 2025

Acquired Bioniz Therapeutics, including two first-in-class clinical-stage assets, EQ101 and EQ102, and. | March 23, 2023 ....

United States , Barbara Troupin , Ono Pharmaceutical Co Ltd , Bank Ltd , Equillium Inc , Exchange Commission , Bruce Steel , Bioniz Therapeutics , Ono Pharmaceutical , Upcoming Milestones , Full Year , Australian Rd Tax Incentive , Cash Used , Adjusted Cash Used , Multi Cytokine Platform , Biocon Limited , Private Securities Litigation Reform Act , Consolidated Statements , Nc Stock Exchange , Press Release , Nd Eq Us29446k1060 ,